- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05067673
Tissue Changes in Lumbar Multifidus After Dry Needling in Subjects With Nonspecific Low Back Pain.
Association Between Tissue Changes in Lumbar Multifidae and Improvement in Pain and Disability After Dry Needling in Subjects With Nonspecific Low Back Pain. Randomized Clinical Trial.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Lower back pain in regarded as the main cause of disability in the world, which has a significant socio-economic impact. Deep dry needling is effective in handling such pain and is one of the techniques of choice by physiotherapists. In this area, the use of ultrasound provides information of interest such as length, thickness, diameter, cross-sectional area or muscle volume, among others.
Objective: Finding out if tissue changes (thickness, histogram and shrinkage rate) that occur in the lumbar multifidus after deep dry needling are related to changes in patient's pain and disability.
It's a double-blind randomized clinical trial in parallel groups. Patients will be randomly divided into 2 groups. One of them will receive dry needling and the other dry needling placebo. The initial, post-needling and a week after evaluations will be performed by a blinded to the intervention therapist.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Madrid
-
Torrejón De Ardoz, Madrid, España, 28850
- Sebastian
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age between 18 and 65 years.
- Nonspecific pain in the lumbar region.
Exclusion Criteria:
- Previous surgery in the lumbosacral spine.
- Osteoporosis.
- Needle phobia.
- Neurogenic pain with positive tests or negative symptoms.
- Red flags: cauda equina syndrome, sudden weight loss, fracture, cancer, infection or systemic diseases.
- Pregnancy.
- Physiotherapy intervention in the 4 weeks prior to the intervention.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador de placebos: Control group
Placebo dry needling
|
Placebo dry needling will be performed with DongBang DB100 Acupuncture Needles which, upon contact with the patient, retract, hiding in the needle handle.
The patient will be in the prone position with a pillow in the abdominal region.
The area will be cleaned with an antiseptic and allowed to air dry for 3 minutes.
At the point indicated by the evaluator, the placebo needle will be placed initially and the introduction of the needle and its location will be simulated with the ultrasound system.
10 repetitions will be performed.
The needle will be removed by depositing it in a needle container and a compression will be made in the treated area.
|
|
Experimental: Experimental group
Dry needling
|
The dry needling will be performed using disposable stainless steel needles (AGU-PUNT needles of size 0.30x50mm or 0.30x60mm depending on the patient) that will be inserted perpendicularly at the point of major hyperalgesia using the Hong technique.
The patient will be in the prone position with a pillow placed in the abdominal region.
The area will be cleaned with an antiseptic and allowed to air dry for 3 minutes.
After this time, the needle will be inserted at the point indicated by the evaluator before reaching the lumbar multifidus by means of echolocation.
Once it is assured that it is in the right place, a total of 10 repetitions are performed.
The needle will be removed by depositing it in a needle container and a compression will be removed in the treated area until hemostasis is achieved.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Changes from baseline in pain on the 10-point Visual Analog Scale (VAS, 0-10 score) at immediatelypost-needling and a week after.
Periodo de tiempo: Baseline, immediately post-needling and a week after.
|
This scale shows concurrent and predictive validity in the assessment of pain.
A difference of 2 points represents a clinically significant change that exceeds the limits of measurement error.
|
Baseline, immediately post-needling and a week after.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Thickness of lumbar multifidus measured with Rehabilitive Ultrasound Imaging in millimeters
Periodo de tiempo: Baseline, immediately post-needling and a week after.
|
Baseline, immediately post-needling and a week after.
|
|
|
Histograms using image analysis
Periodo de tiempo: Baseline, immediately post-needling and a week after.
|
Baseline, immediately post-needling and a week after.
|
|
|
Pressure Pain threshold
Periodo de tiempo: Baseline, immediately post-needling and a week after.
|
It will be measured by using a pressure algometer.
Lumbar multifidus algometry is performed approximately 1.5 cm from the spinous process of the level to be evaluated.
The measurement will be taken 3 times to avoid variability by instructing patients to say verbally when they begin to feel pain.
|
Baseline, immediately post-needling and a week after.
|
|
Disability
Periodo de tiempo: Baseline, immediately post-needling and a week after.
|
it will be measured using the Roland-Morris questionnaire.
Values range from 0 (absence of disability) to 24 (maximum level of disability).
|
Baseline, immediately post-needling and a week after.
|
|
Contraction time measured in milliseconds with M-mode
Periodo de tiempo: Baseline, immediately post-needling and a week after.
|
The patient performs a hip extension in the prone position
|
Baseline, immediately post-needling and a week after.
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 210108
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Lumbalgia
-
University Hospital, GrenobleReclutamientoPacientes con EII, tratamiento original, biosimilar, Switch BackFrancia
-
Université Victor Segalen Bordeaux 2Nanox International Laboratory (Belgique)TerminadoEficacia y Tolerancia de B-Back® en el Síndrome de BurnoutFrancia
-
Shanghai Henlius BiotechReclutamientoHER2-LOW Hormonas receptor de cáncer de mama positivoPorcelana
-
Aminex Therapeutics, Inc.ReclutamientoMelanoma (cáncer de piel) | HER2-LOW Hormonas receptor de cáncer de mama positivoEstados Unidos
Ensayos clínicos sobre Placebo dry needling
-
Université de SherbrookeCHU de Quebec-Universite Laval; Centre de recherche du Centre hospitalier universitaire... y otros colaboradoresReclutamientoVestibulodinia provocadaCanadá
-
The Mentholatum CompanyTerminadoOjo seco | Síndromes del ojo secoEstados Unidos
-
Baylor College of MedicineRetiradoDisplasia del desarrollo de la caderaEstados Unidos
-
University of IowaTerminadoMandíbula edéntula | Boca edéntulaEstados Unidos
-
Avizor SAReclutamiento
-
Fredrik IredahlPrimary Health Care Center, Department of Health Medicine and Caring Sciences...TerminadoHerida | Úlcera, Pierna | Heridas exudativasSuecia
-
McMaster UniversityTerminadoNeoplasias Pulmonares | Derrame pleuralCanadá
-
Washington University School of MedicineTerminadoNeoplasias pancreáticasEstados Unidos
-
Nova Scotia Health AuthorityTerminadoNeumotórax | AtelectasiaCanadá
-
Boehringer IngelheimTerminadoDermatitis Atópica